Phase 2 trial tests leukemia drug bosutinib against external controls in ALS
A phase 2 open-label trial evaluated the safety and exploratory efficacy of the repurposed leukemia drug bosutinib in patients with ...
A phase 2 open-label trial evaluated the safety and exploratory efficacy of the repurposed leukemia drug bosutinib in patients with ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.